1993 – 1999 American Urological Association: Healthcare Policy Committee 
 

      1993 – 1999   Mid-Atlantic Section, American Urological        Association:  Socioeconomics Committee Chairman 
 

      1993 - PRESENT  Board Member, American Prostate Society

                              Baltimore, Maryland 
 

      1993 – 1997   American Cancer Society:  Cancer Care        Committee 
 

      1993    Maryland Department of Health and Mental        Hygiene:  Cancer Detection Task Force 
 

      1995 – 1997   Chairman, Prostate Cancer Detection Committee for      Maryland, American Cancer Society 
 

      1996 – 2002   Board Member, American Association of Clinical       Urologists 
 

1999 – PRESENT American Urological Association:  Investment Committee 
 

2002-2003 President, American Association of Clinical Urologists 
 
 

GRANT SUPPORT:   
 

11/1/92 to 11/1/94   Naslund, M.J., P. I.:  A Clinical Trial Comparing the Safety and Efficacy of Alpha Blockade and Androgen Suppression for the Treatment of Benign Prostatic Hyperplasia.  Veterans Administration Cooperative Study #359.    Total amount of award $160,000. 
 

3/3/93 to 3/3/94   Naslund, M.J., P. I.:  Prostate Disease Detection. Maryland Department of Health and Mental Hygiene.    Total amount of award $75,000. 
 

5/1/95 to 5/1/97   Naslund, M.J., P. I.:  A Multicenter Clinical Investigation of Transurethral Needle Ablation (TUNA) in Patients with Benign Prostatic Hyperplasia. VIDAMED CORP. Total amount of award  $270,000. 
 

6/95 to 6/02    Jacobs, S.C. and Naslund, M.J., Co-P. I.:  Medical Therapy in Benign Prostatic Hyperplasia. NIH #1UOIDK49880-01.  Total amount of award $1,876,000. 
 

5/01 to 5/02    Naslund, M.J., PI:  A Randomized Study with Microwave Uroplasty and Proscar For The Treatment of Benign Prostatic Hyperplasia.  Celsion Corp.  Total amount of award $9,000. 
 

11/01 to 6/04    Naslund, M.J., PI:  Long-Term Efficacy and Safety of Alfuzosin On The Risk Of Acute Urinary Retention and the Need For Surgery in Patient with Benign Prostatic Hyperplasia.  A Two-Year Randomized Multi-Center Double Blind Parallel Group Placebo-Controlled Study. Sanofi-Synthelabo Corp. Total amount of award $140,000. 
 

9/02  to9/08    Naslund, M.J., PI: Alternative Therapies for Benign Prostatic Symptoms. NIH# 1U01 DK63778-01.  Total amount of award $2,050,000. 
 

11/02 to 5/07    Naslund, M.J., PI: A Randomized, Double-blind, Placebo Controlled, Parallel Group Study of the Safety and Efficacy of Dutasteride 0.5mg. for  Four Years in the Prevention of Prostate Cancer. Glaxo-SmithKline. Total amount of award $200,000. 
 
 
 

PUBLICATIONS: 
 

1. Naslund, M.J., Pearson, T.A. and Ritter, J.A.:  A documented episode of pulmonary vasoconstriction and systemic sclerosis.  Johns Hopkins Medical Journal, 148:(2) 78,1981. 
 

2. Naslund, M.J. and Coffey, D.S.:  The differential effects of neonatal androgen, estrogen and progesterone on adult rat prostate growth.  Journal of Urology, 136:  1136, 1986. 
 

3. Naslund, M.J. and Coffey, D.S.:  The hormonal imprinting of the prostate and the regulation of stem cells in prostatic growth.  Benign Prostatic Hyperplasia, Volume 2, p. 73, 1987.  NIH Publication No. 87-2887, U.S. Govt. Printing Office, Washington, D.C. 
 

4. Naslund, M.J., Strandberg, J.D. and Coffey, D.S.:  The role of androgens and estrogens in the pathogenesis of experimental non-bacterial prostatitis.  Journal of Urology, 140:1049, 1988. 
 

5. Naslund, M.J., Gearhart, J.P. and Jeffs, R.D.:  Laparoscopy:  Its selected use in patients with unilateral non-palpable testis after HCG stimulation.  Journal of Urology, 142:108, 1989. 
 

6. Jacobs, S.C., Campbell, Jr., E.W. and Naslund, M.J.:  Current Status of Cancers of  
             the Bladder and Prostate.  Transactions of ALIMDA, 74:144, 1990. 
 

7. Hildebrand, R.K., Naslund, M.J., Oesterling, J.E. and Coffey, D.S.:   The influence  
            of age, strain and the testes on rat hormone sensitivity.  Prostate, 18:81, 1991. 
 

8. Naslund, M.J.:  Vesical fistulae.  In:  Operative Urology, Edited by F. F. Marshall, Philadelphia:  W. B. Saunders, Co.  Chapt. 22, pp 151-156, 1991. 
 

9. Naslund, M.J.: Vasectomy.  In:  Operative Urology, Edited by F. F. Marshall,   Philadelphia:  W. B. Saunders, Co.  Chapt. 52, pp. 397-398, 1991. 
 

10. Naslund, M.J., Dement, S. and Marshall, F.F.:  Malignant renal schwannoma.   Urology, 38:(5) 477-479, 1991. 
 

11. Quinlan, D.M., Brendler, C.B. and Naslund, M.J.:  Urological Applications of the  Argon  Beam Coagulator.  Journal of Urology,  147:410, 1992. 
 

12. Naslund, M.J., Campbell, E.W., Jr., Jacobs, S.C.:  Laparoscopic Pelvic Lymph Node Dissection.  Journal of Urological Nursing, 11:20, 1992. 
 

13. Steiner, M.S., Naslund, M.J., Stutzman, R.E.:  Modified Thoraco-Abdominal  Approach for Retroperitoneal Lymphadenectomy.  Journal of Urology, 149:23,  
            1993. 
 

14. Thompson, R.A., Campbell, E.W. Jr., Kramer, H.C., Jacobs, S.C., and Naslund,  
             M.J.;  Late Invasive Recurrence Despite Long-Term Surveillance for Superficial  
             Bladder Cancer. Journal of Urology 149: 1010, 1993 
 

15. Choe, J.W., Campbell, E.W., Jr., Naslund, M.J., Jacobs, S.C.:  Management of Renal Carcinoma.  In:  Practice of Urology (eds Smith, J., Stein, B. )  New York:  Norton Medical Books, 1993, Vol 2  pp. 1-23. 
 

16. Hader, J.E., Marzella, L. Myers, R.A.M., Jacobs, S.C., Naslund, M.J.: Hyperbaric Oxygen Treatment for Experimental Cyclophosphamide induced Hemorrhagic Cystitis. Journal of Urology  149; 1617, 1993. 
 

17. Burney, T.L., Campbell, E.W., Jr., Naslund, M.J., Jacobs, S.C.:  Complications of Staging Laparoscopic Pelvic Lymphadenectomy.   Surgical Laparoscopy Endo   3: 184-190, 1993. 
 

18. Burney, T.L., Jacobs, S.C., Naslund, M.J.: Small bowel obstruction following  laparoscopic lymph adenectomy, Journal of Urology 150:  1515, 1993. 
 

19. Naslund, M.J., Sklar, G.N., and Jacobs, S.C.:  The Prostate:  Why Does It Enlarge? What Should I Do About It.  The American Prostate Society Update Network.  Producer Shirley Gerard.  The Aherne Group/Monumental Films, 1994. 
 

20. Naslund, M.J.: The Economics of Health Care Reform.  Urology 44:  299, 1994 
 

21. Benoit, R.M., and Naslund, M.J.: An Economic Rationale for Prostate  Cancer  Screening.  Urology  44:  795, 1994 
 

22. Naslund, M.J.:  Cost Considerations in the Treatment of BPH.  American Journal of Medicine Suppl. Current Management of Benign Prostatic Hyperplasia: Nov. 23, 1994. 
 

23.  Naslund, M.J., Campbell, E.W., Jr.,  Jacobs, S.C.:  Pelvic Lymphadenectomy.  In:   Complications of Laparoscopic Surgery  (ed. Robert W. Bailey, M.D.) St. Louis:  Quality Medical Publishing, Inc.; Ch. 14 pp 341-361, 1995. 
 

24. Campbell, E.W., Jr., Jacobs, S.C., Naslund, M.J.: Complications of Laparoscopic Urologic Surgery:  Miscellaneous Urologic Procedures in:  Complications of Laparoscopic Surgery  ed. R. W. Bailey and J. L. Flowers: St. Louis:  Quality Medical Publishing, Inc.; Ch. 13, pp 329-340, 1995.  
 

25. Benoit, R.M. and Naslund, M.J.:  Detection of Latent Prostate Cancer from Routine  Screening:  Comparison with Breast Cancer Screening.  Urology 46:  533, 1995. 
 

26. Sklar, G.N., Koskorove, G., Filderman, P.S., Naslund, M.J. and Jacobs, S.C.:   Laparoscopic Monitoring of Cryosurgical Ablation of the Prostate.  Surgical  Laparoscopy & Endoscopy  5 (5):  376-81, 1995.

27. Naslund, M.J. and Stitcher, M.F.: A Cost Comparison of TUNA vs. TURP.   Journal of Urology 157: 155A, 1997. 
 

28. Mackey, T.J., Flowers, J.L., Bartlett, S.T., Cho, E., Jacobs, S.C. and Naslund,  M.J.:  Cost Comparison of Laparoscopic vs. Open Donor Nephrectomy Analyzing  Provider Charges and Productivity Loss.  Journal of Urology 157: 156A, 1997. 
 

29. Benoit, R.M. and Naslund, M.J.:  Socioeconomic Effects of Prostate Cancer  Screening.  Urologic Clinics of North America 24(2):  451, 1997. 
 

30. Naslund, M.J.:  Transurethral Needle Ablation of the Prostate.  

      Urology  50 167,  1997.  
 

31. Benoit, R.M. and Naslund, M.J.:  The Economics of Prostate Cancer Screening.   Oncology 11: 1533, 1997. 
 

32. Benoit, R.M. and Naslund, M.J.:  The Economics of Prostate Cancer Screening.

      Primary Care and Cancer 17:9, 1997. 
 

33. Roehrbron, C.G., Issa, M.M., Bruskewitz, R.C., Naslund, M.J., Oesterling, J.E., Perez-Marrero, R., Shumaker, B.P. and Narayan, P.:  Transurethral Needle Ablation for Benign Prostatic Hyperplasia: Twelve Month Results of a Prospective Multicenter U.S. Study.  Urology, 51: 415, 1998. 
 

34. Bruskewitz, R.C., Issa, M.M., Roehrbron, C.G., Naslund, M.J., Perez-Marrero, R., Shumaker, B.P. and Oesterling, J.E.:  A Prospective, Randomized One Year Clinical Trial Comparing Transurethral Needle Ablation to Transurethral Resection of the Prostate for the Treatment of Symptomatic Benign Prostatic Hyperplasia.  Journal of Urology, 159: 1588, 1998.

35. Gee, W.H., Holtgrewe, H.L., Blute, M.L., Miles, B.J., Naslund, M.J., Nellans, R.E., O’Leary, M.P., Thomas, R., Painter, M.R., Meyer, J.J., Rohner, T.J., Cooper, T.P., Blizzard, R., Fenninger, R.B., and Emmons, L.:  1997 American Urological Association Galant Survey:  Changes in Diagnosis and Management of Prostate Cancer and Benign Prostatic Hyperplasia, and Other Practice Trends From 1994 to 1997.  Journal of Urology, 160:  1804, 1998.

36. Sperry, R.J., Naslund, M.J., and Baum, N.:  The Principles of Economic Analysis.  Costs and Quality:  5, 7-11, 1999.

37. Roehrborn, C.J., Burkhard, F.C., Bruskewitz, R.C., Issa, M.M., Perez-Marrero, R., Naslund, M.J., and Shumaker, B.P.:  The Effects of Transurethral Needle Ablation and Resection of the Prostate on Pressure Flow Urodynamic Parameters:  Analysis of the United States Randomized Study.  Journal of Urology, 162:  92, 1999.

38. O’Leary, M.P., Gee, W.F., Holtgrewe, H.L., Blute, M.L., Cooper, T.P.  Meyer, J.J., Miles, B.J., Naslund, M.J., Nellans, R.E., Thomas, R., Painter, M.R., Blizzard, R., and Fenninger, R.B.:  1998 American Urological Association Gallup Survey:  Changes in Physician Practice Patterns, Treatment of Ureteral Stones and Impact of Managed Care.  Journal of Urology, 162:  1702, 1999.

39. Mathews, R., Naslund, M., and Docimo, S.:  Cost Analysis of the Treatment of Vesicoureteral Reflux:  A Computer Model.  Journal of Urology, 163:  561, 2000.

40. Benoit, R.M., Naslund, M.J., and Cohen, J.K.:  Complications After Prostate Brachytherapy In the Medicare Population.  Urology, 55:  91, 2000.

41. Chon, J.K., Jacobs, S.C., and Naslund, M.:  The Cost Value of Medical Versus Surgical Hormonal Therapy for Metatastatic Prostate Cancer.  Journal of Urology, 164:  735, 2000.

42. Naslund, M., Bay-Nielsen, H., Holtgrewe, L., Homma, Y., and Melchior, H.:  The Economics of Benign Prostatic Hyperplasia.  In:  Benign Prostatic Hyperplasia, Ed. by Chatelain, C., Denis, L., Foo, K., Khoury, S., and McConnell, J., Plymouth, U.K.:  Health Publications Ltd.  Chapter 2 pp. 69-78, 2001.

43. Benoit, R.M., Gronberg, H., and Naslund, M.J.:  A Quantitative Analysis of the Costs and Benefits of Prostate Cancer Screening.  Prostate Cancer and Prostatic Diseases 4:  138-145, 2001.

44. Dibiase, S.J., Hosseinzadeh, K., Gullapalli, R.P., Jacobs, S.C., Naslund, M.J., Sklar, G.N., Alexander, R.B. and Yu, C.:  Magnetic Resonance Spectroscopic Imaging-Guided Brachytherapy For Localized Prostate Cancer.  Int. J. Radiation Oncology Biol. Phys. 52:  429, 2002.

45. Kwok, Y., DiBiase, SJ, Amin, P., Naslund, M., Sklar, G, and Jacobs, S.C.: Risk Group Stratification In Patients Undergoing Permanent I ¹²⁵ Prostate Brachytherapy As Monotherapy. Int. J. Radiation Oncology Biol. Phys., Vol. 53, No.3, pp. 558, 2002.

46. Benoit, R.M., Wise, B.V., Naslund, M.J., Mathews, R., and Docimo, S.G.:  The Effect of Dysfunctional Voiding On The Costs of Treating Vesicoureteral Reflux:  A Computer Model.  Journal Of Urology, 168:  2173, 2002.

47. Hill, B., Belville, W., Bruskewitz, R., Issa, M., Perez-Marrero, R., Roehrborn, C., Terris, M. and Naslund, M.  Transurethral Needle Ablation vs. Transurethral Resection of the Prostate for the Treatment of Symptomatic Benign Prostatic Hyperplasia:  5-Year Results of a Prospective Randomized Multi-Center Clinical Trial.  Journal of Urology 171: 2336, 2004.

48. Naslund, M.J.:  What Is The Role of Combination Medical Therapy In Treating Prostatic Symptoms?  Pri-Med In Practice.  3:  2, 2005. 

49. Naslund, M.J., Carlson, A.M., and Williams, M.J.:  A Cost Comparison of Medical Management and Transurethral Needle Ablation for Treatment of Benign Prostatic Hyperplasia During a 5-Year Period.  Journal of Urology, 173:  2090, 2005.